Mechanisms of tumor immune escape in triple-negative breast cancers (TNBC) with and without mutated BRCA 1

被引:0
|
作者
Jörg B. Engel
Arnd Honig
Michaela Kapp
Jens C. Hahne
Susanne R. Meyer
Johannes Dietl
Sabine E. Segerer
机构
[1] Universitätsfrauenklinik Regensburg,
[2] Caritas Krankenhaus St Josef,undefined
[3] Universitätsfrauenklinik Würzburg,undefined
来源
关键词
Triple negative breast cancer; Treg infiltration; Tumor immune escape; AKT;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:141 / 147
页数:6
相关论文
共 50 条
  • [1] Mechanisms of tumor immune escape in triple-negative breast cancers (TNBC) with and without mutated BRCA 1
    Engel, Joerg B.
    Honig, Arnd
    Kapp, Michaela
    Hahne, Jens C.
    Meyer, Susanne R.
    Dietl, Johannes
    Segerer, Sabine E.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 289 (01) : 141 - 147
  • [2] Mechanisms of Tumor Immune Escape in Triplenegative Breast Cancers (TNBC) with and without Mutated BRCA 1
    Segerer, S. E.
    Kapp, M.
    Hahne, J. C.
    Dietl, J.
    Engel, J. B.
    CANCER RESEARCH, 2011, 71
  • [3] Molecular profiling comparison of BRCA1/2-mutated and BRCA1/2 non-mutated triple-negative breast cancer (TNBC)
    Arguello, D.
    Abbott, B.
    Reddy, S.
    Gatalica, Z.
    Obeid, E.
    Goldstein, L.
    CANCER RESEARCH, 2016, 76
  • [4] Triple-negative breast cancer arising in a fibroadenoma in BRCA 1 mutated patient
    Brunetti, Nicole
    Valente, Irene
    Pitto, Francesca
    Calabrese, Massimo
    JOURNAL OF MEDICAL ULTRASOUND, 2023, 31 (01) : 63 - 65
  • [5] 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
    Peter Bouwman
    Amal Aly
    Jose M Escandell
    Mark Pieterse
    Jirina Bartkova
    Hanneke van der Gulden
    Sanne Hiddingh
    Maria Thanasoula
    Atul Kulkarni
    Qifeng Yang
    Bruce G Haffty
    Johanna Tommiska
    Carl Blomqvist
    Ronny Drapkin
    David J Adams
    Heli Nevanlinna
    Jiri Bartek
    Madalena Tarsounas
    Shridar Ganesan
    Jos Jonkers
    Nature Structural & Molecular Biology, 2010, 17 : 688 - 695
  • [6] Rare triple-negative breast cancers (TNBC): An NCDB analysis.
    Elimimian, Elizabeth Blessing
    Samuel, Thomas A.
    Liang, Hong
    Bilani, Nadeem
    Elson, Leah
    Nahleh, Zeina A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
    Bouwman, Peter
    Aly, Amal
    Escandell, Jose M.
    Pieterse, Mark
    Bartkova, Jirina
    van der Gulden, Hanneke
    Hiddingh, Sanne
    Thanasoula, Maria
    Kulkarni, Atul
    Yang, Qifeng
    Haffty, Bruce G.
    Tommiska, Johanna
    Blomqvist, Carl
    Drapkin, Ronny
    Adams, David J.
    Nevanlinna, Heli
    Bartek, Jiri
    Tarsounas, Madalena
    Ganesan, Shridar
    Jonkers, Jos
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2010, 17 (06) : 688 - U56
  • [8] BRCA1a has antitumor activity in triple-negative breast cancers
    Yuli, C.
    Shao, N.
    Oprea-Ilies, G.
    Okoli, J.
    Reddy, E. S. P.
    Rao, V. N.
    BREAST CANCER RESEARCH, 2007, 9 (01)
  • [9] BRCA1a has antitumor activity in triple-negative breast cancers
    C Yuli
    N Shao
    G Oprea-llies
    J Okoli
    ESP Reddy
    VN Rao
    Breast Cancer Research, 9
  • [10] Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers
    Gruosso, Tina
    Gigoux, Mathieu
    Manem, Venkata Satya Kumar
    Bertos, Nicholas
    Zuo, Dongmei
    Perlitch, Irina
    Saleh, Sadiq Mehdi Ismail
    Zhao, Hong
    Souleimanova, Margarita
    Johnson, Radia Marie
    Monette, Anne
    Ramos, Valentina Munoz
    Hallett, Michael Trevor
    Stagg, John
    Lapointe, Rejean
    Omeroglu, Atilla
    Meterissian, Sarkis
    Buisseret, Laurence
    Van den Eynden, Gert
    Salgado, Roberto
    Guiot, Marie-Christine
    Haibe-Kains, Benjamin
    Park, Morag
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (04): : 1785 - 1800